413 results
Page 2 of 21
8-K
jzjb4pc ts5d58ua0z0s
23 Dec 22
Regulation FD Disclosure
8:49am
8-K
EX-99.1
m7lr7kz5wt lky
22 Dec 22
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
8:15am
8-K
EX-99.1
znlnxkmwq
21 Dec 22
Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing
7:00am
8-K
EX-99.1
655kxia0
5 Dec 22
Other Events
8:00am
8-K
EX-99.1
atv vg9v8cx6pwtesmr
14 Nov 22
Acorda Therapeutics Announces Passage of Reverse Stock Split Proposal at its Special Meeting of Stockholders
6:07am
8-K
EX-99.1
5dtrc75zpi
4 Nov 22
Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
9:45am
DEFA14A
1jjra7nw
1 Nov 22
Additional proxy soliciting materials
4:12pm
8-K
EX-99.1
flo6dw
1 Nov 22
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm
DEFA14A
eqs3x
28 Oct 22
Additional proxy soliciting materials
9:37am
8-K/A
EX-99.1
pyuyi1n2b23skd4av
28 Oct 22
Other Events
9:37am
DEFA14A
5gb0wir6os
27 Oct 22
Additional proxy soliciting materials
7:19am
8-K
EX-99.1
jtc1btcn
27 Oct 22
Other Events
7:17am
DEFA14A
ks69dshrlu6d5kznygka
21 Oct 22
Additional proxy soliciting materials
4:10pm
DEFA14A
lkw eqse8r
19 Oct 22
Additional proxy soliciting materials
4:07pm
8-K
EX-99.1
loeywc67p erpow
19 Oct 22
ISS, Glass Lewis and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split
4:05pm
8-K
EX-99.1
sz9x9jr6e4msq4
18 Oct 22
Other Events
1:00pm
8-K
EX-99.1
3rpspsrvqstf
17 Oct 22
Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case
9:00am
DEFA14A
s69a ixkb8mfhf9n
11 Oct 22
Additional proxy soliciting materials
9:27am
8-K
EX-99.1
kenkxf
11 Oct 22
Acorda Therapeutics Withdraws Proposal to Increase Authorized Shares from Special Meeting of Stockholders
9:26am